Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins

Protein Expression and Purification

Volumn 48, Issue 1, 2006, Pages 14-23

  Ivanov, Alexander V ^a,b   Korovina, Anna N ^a   Tunitskaya, Vera L ^a   Kostyuk, Dmitry A ^a   Rechinsky, Vladimir O ^a   Kukhanova, Marina K ^a   Kochetkov, Sergey N ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Hepatitis C virus; High level expression; RNA dependent RNA polymerase

Indexed keywords

ESCHERICHIA COLI; HEPATITIS C VIRUS;

EID: 33646868556     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.02.011     Document Type: Article

References (39)

1. Rosen H.R., and Gretch D.R. Hepatitis C virus: current understanding and prospects for future therapies. Mol. Med. Today 5 (1999) 393-399
2. Oh J.W., Sheu G.T., and Lai M.M. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J. Biol. Chem. 275 (2000) 17710-17717
3. De Francesco R., Tomei L., Altamura S., Summa V., and Migliaccio G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 58 (2000) 1-16
4. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J. Mol. Biol. 313 (2001) 451-464
5. Behrens S.-E., Tomei L., and De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 15 (1996) 12-22
6. Waris A., Sarker S., and Siddiqui A. Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA 10 (2004) 321-329
7. Lohmann V., Korner F., Herian U., and Bartenschlager R. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71 (1997) 8416-8428
8. Choi H.B., Kim Y.G., and Oh J.W. Biochemical properties of full-length hepatitis C virus RNA-dependent RNA polymerase expressed in insect cells. Exp. Mol. Med. 35 (2003) 475-485
9. Yamashita T., Kaneko S., Shirota Y., Qin W., Nomura T., Kobayashi K., and Murakami S. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J. Biol. Chem. 273 (1998) 15479-15486
10. Al R.H., Xie Y., Wang Y., and Hagedorn C.H. Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli. Virus Res. 53 (1998) 141-149
11. Ferrari E., Wright-Minogue J., Fang J.W.S., Baroudy B.M., Lau J.Y.N., and Hong Z. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J. Virol. 73 (1999) 1649-1654
12. Oh J.W., Ito T., and Lai M.M. A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J. Virol. 73 (1999) 7694-7702
13. Tomei L., Vitale R.L., Incitti I., Serafini S., Altamura S., Vitelli A., and De Francesco R. Biochemical characterization of hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence. J. Gen. Virol. 81 (2000) 759-767
14. Ranjith-Kumar C.T., Gajewski J., Gutshall L., Maley D., Sarisky R.T., and Kao C.C. Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis. J. Virol. 75 (2001) 8615-8623
15. Adachi T., Ago H., Habuka N., Okuda K., Komatsu M., Ikeda S., and Yatsunami K. The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase. Biochim. Biophys. Acta 1601 (2002) 38-48
16. Stuyver L.J., Whitaker T., McBrayer T.R., Hernandez-Santiago B.I., Lostia S., Tharnish P.M., Ramesh M., Chu C.K., Jordan R., Shi J., Rachakonda S., Watanabe K.A., Otto M.J., and Schinazi R.F. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture. Antimicrob. Agents Chemother. 47 (2003) 244-254
17. Wang Q.M., Johnson R.B., Chen D., Leveque V.J., Ren J., Hockman M.A., Abe K., Hachisu T., Kondo Y., Isaka Y., Sato A., and Fujiwara T. Expression and purification of untagged full-length HCV NS5B RNA-dependent RNA polymerase. Protein Expr. Purif. 35 (2004) 304-312
18. Ivanov A.V., Kozlov M.V., Kuzyakin A.O., Kostyuk D.A., Tunitskaya V.L., and Kochetkov S.N. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Biochemistry (Moscow) 69 (2004) 782-788
19. Carroll S.S., Tomassini J.E., Bosserman M., Getty K., Stahlhut M.W., Eldrup A.B., Bhat B., Hall D., Simcoe A.L., LaFemina R., Rutkowski C.A., Wolanski B., Yang Z., Migliaccio G., De Francesco R., Kuo L.C., MacCoss M., and Olsen D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 278 (2003) 11979-11984
20. Rechinsky V.O., Chernov B.K., Dragan S.M., Kostyuk D.A., Tunitskaya V.L., and Kochetkov S.N. Targeted mutagenesis identifies Asp-569 as a catalytically critical residue in T7 RNA polymerase. Mol. Gen. Genet. 247 (1995) 110-113
21. Aiba H., Adhya S., and de Crombrugghe B. Evidence for two functional gal promoters in intact Escherichia coli cells. J. Biol. Chem. 256 (1981) 11905-11910
22. Sun L., and Fuchs J.A. Escherichia coli ribonucleotide reductase expression is cell cycle regulated. Mol. Biol. Cell 1 (1992) 1095-1105
23. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning (1989), Cold Spring Harbor Laboratory Press, New York
24. Mashko S.V. The optimization of expression of heterologous genes in E. coli cells. Biotechnology (Moscow) (1998) 3-23
25. Brodsky L.I., Vasilyev A.V., Kalaydzidis Ya.L., Osipov Yu.S., Tatuzov A.R.L., and Feranchuk S.I. GeneBee: the program package for biopolymer structure analysis. Dimacs 8 (1992) 127-139
26. Brodsky L.I., Ivanov V.V., Kalaydzidis Ya.L., Leontovich A.M., Nikolaev V.K., Feranchuk S.I., and Drachev V.A. GeneBee-NET: internet-based server for analyzing biopolymers structure. Biochemistry (Moscow) 60 (1995) 923-928
27. Schoner B.E., Belagaje R.M., and Schoner R.G. Enhanced translational efficiency with two-cistron expression system. Methods Enzymol. 185 (1990) 94-103
28. Shirota Y., Luo H., Qin W., Kaneko S., Yamashita T., Kobayashi K., and Murakami S. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J. Biol. Chem. 277 (2002) 11149-11155
29. Makrides S.C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60 (1996) 512-538
30. Baneyx F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10 (1999) 411-421
31. Nakamura Y., Gojobori T., and Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28 (2000) 292
32. Novy R., Drott D., Yaeger K., and Mierendorf R. Overcoming the codon bias of E. coli for enhanced protein expression. Innovations 12 (2001) 1-3
33. Voges D., Watzele M., Nemetz C., Wizemann S., and Buchberger B. Analyzing and enhancing mRNA translational efficiency in an Escherichia coli in vitro expression system. Biochem. Biophys. Res. Commun. 318 (2004) 601-614
34. Uhlenbeck O.C., Baller J., and Doty P. Complimentary oligonucleotide binding to the anticodon of fMet-transfer RNA. Nature 225 (1970) 508-510
35. Schoner B.E., Belagaje R.M., and Schoner R.G. Translation of a synthetic two-cistron mRNA in Escherichia coli. Proc. Natl. Acad. Sci. USA 83 (1986) 8506-8510
36. Mukhopadhyay U.K., and Sahni G. An insight into the possible mechanism of working of two-cistronic gene expression systems and rational designing of newer systems. J. Biosci. 27 (2002) 219-231
37. Schoner B.E., Hsiung H.M., Belagaje R.M., Mayne N.G., and Schoner R.G. Role of mRNA translational efficiency in bovine growth hormone expression in Escherichia coli. Proc. Natl. Acad. Sci. USA 81 (1984) 5403-5407
38. Bucheler U.S., Werner D., and Schirmer R.H. Random silent mutagenesis in the initial triplets of the coding region: a technique for adapting human glutathione reductase-encoding cDNA to expression in Escherichia coli. Gene 96 (1990) 271-276
39. Huang L., Sineva E.V., Hargittai M.R., Sharma S.D., Suthar M., Raney K.D., and Cameron C.E. Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli. Protein Expr. Purif. 37 (2004) 144-153